Strategic acquisitions WellSpring recently expanded its skincare portfolio through the acquisition of DerMend and Recticare from Ferndale Brands, signaling a growth trajectory in therapeutic skincare that could benefit from co-promotional OTC and personal care formulations.

Healthcare focus With a concentrated OTC and personal care product lineup and a private equity-backed growth path, there are opportunities to partner on private-label or exclusive distribution deals in the U.S. and Canadian markets.

Mid-market footprint Company size (51-200 employees) and revenue in the mid-range present a path for targeted enterprise sales, channel partnerships, and scalable manufacturing or packaging services for expanding product lines.

North America emphasis Headquartered in Florida with active U.S. and Canadian market focus suggests strong potential for regional distribution, regulatory-compliant activities, and co-development for localized SKUs or reformulations.

Private equity backing Backing from Avista and prior investment signals a growth-oriented mindset, making WellSpring receptive to strategic partnerships, accelerators, and joint ventures to accelerate go-to-market for new OTC and skincare brands.